ADDEX THERAPEUTICS LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1155 CHF | +0.43% |
|
-23.26% | +151.09% |
| 24/04 | Top Premarket Decliners | MT |
| 18/04 | Transcript : Addex Therapeutics Ltd, 2023 Earnings Call, Apr 18, 2024 |
Chart calendar Addex Therapeutics Ltd
113081f812a73b1e7e9.UtIOTvYOSxLY1FKu8b-gwAYsgLJeuKR-2IpGnGOekoo.PZlAfoFMM1rr4Tf2nO3DgjdC-Pc1zeIdsdMp9DP_yrs5llEfmjkaXL-_OQ~637aacb6ad7d31581e12e09ff3671c4f
Upcoming events on Addex Therapeutics Ltd
Past events on Addex Therapeutics Ltd
| 23/04/2024 05:15 pm | Swiss Biotech Day |
| 22/04/2024 | Swiss Biotech Day |
| 18/04/2024 07:30 pm | Q4 2023 Earnings Call |
| 18/04/2024 10:30 am | Q4 2023 Earnings Release |
| 19/03/2024 03:30 pm | BioEurope Spring Conference |
| 11/01/2024 08:50 pm | Swiss Equities Baader Conference |
| 09/01/2024 06:00 am | Biotech Showcase |
| 19/12/2023 03:30 pm | Extraordinary Shareholders Meeting |
| 29/11/2023 08:30 pm | Q3 2023 Earnings Call |
| 29/11/2023 11:30 am | Q3 2023 Earnings Release |
| 14/11/2023 | Jefferies London Healthcare Conference |
| 06/11/2023 | Bio-Europe Conference |
| 14/09/2023 12:30 am | H.C. Wainwright Global Investment Conference - Pre - Recorded |
| 13/09/2023 | SCI RSC Medicinal Chemistry Symposium |
| 10/08/2023 07:30 pm | Q2 2023 Earnings Call |
| 10/08/2023 10:30 am | Q2 2023 Earnings Release |
| 31/05/2023 02:30 pm | Annual General Meeting |
| 14/05/2023 | BioEquity Europe Conference |
| 11/05/2023 07:30 pm | Q1 2023 Earnings Call |
| 11/05/2023 10:30 am | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 2,76 3,49 -20.89% | 3,88 2,85 36.19% | 3,15 3,48 -9.29% | 1,45 1,15 25.65% | 1,65 1,10 49.73% | 0,00 |
|
EBITDA Million CHF | Released Forecast Spread | -14,3 -10,8 -32.13% | -11,9 -15,5 23.57% | -15,2 -15,6 2.52% | -20,2 -16,6 -22.04% | 0,00 -10,1 - | -7,39 |
|
EBIT Million CHF | Released Forecast Spread | -14,6 -11,4 -28.12% | -12,2 -15,7 22.16% | -15,5 -15,6 0.31% | -20,5 -16,9 -21.64% | -10,3 -10,3 0.27% | -7,39 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -14,8 -11,0 -34.37% | -12,9 -16,2 20.62% | -15,4 -15,4 0.21% | -20,8 -17,0 -22.74% | -10,6 -11,3 6.58% | -6,30 |
|
Net income Million CHF | Released Forecast Spread | -14,8 -11,0 -34.37% | -12,9 -40,9 68.56% | -15,4 -15,4 0.21% | -20,8 -17,0 -22.74% | -10,6 -11,3 6.58% | -6,30 |
|
EPS CHF | Released Forecast Spread | -0,56 -0,42 -33.33% | -0,48 -0,62 22.58% | -0,45 -0,43 -3.85% | -0,46 -0,42 -10.84% | -0,14 -0,17 17.65% | -0,09 |
| Announcement Date | 08/04/20 | 11/03/21 | 10/03/22 | 30/03/23 | 18/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 0,40 0,48 -15.77% | 0,24 0,47 -48.09% | 0,19 0,51 -63.53% | 0,42 0,23 84.76% | 0,33 0,64 -48.67% | 0,15 0,65 -76.43% | 0,70 | 0,70 | 0,70 | 0,70 | |
|
EBIT Million CHF | Released Forecast Spread | -4,28 -4,30 0.67% | -5,76 -4,03 -43% | -7,09 -6,49 -9.28% | -4,17 -4,98 16.24% | -2,65 -2,31 -14.85% | -2,68 -2,55 -5.23% | |||||
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -4,42 -4,33 -2.24% | -5,82 -4,06 -43.63% | -7,22 -6,52 -10.84% | -4,11 -5,08 19.06% | -2,62 -2,43 -7.74% | -2,86 -2,65 -7.85% | |||||
|
Net income Million CHF | Released Forecast Spread | -4,42 -4,33 -2.24% | -5,82 -4,06 -43.63% | -7,22 -6,52 -10.84% | -4,11 -5,08 19.06% | -2,68 | -2,62 -2,43 -7.74% | -2,86 -2,65 -7.85% | ||||
|
EPS CHF | Released Forecast Spread | -0,13 -0,10 -30% | -0,15 -0,08 -87.5% | -0,19 -0,13 -46.15% | -0,09 -0,09 0% | -0,04 | -0,03 -0,03 0% | -0,03 -0,03 0% | -0,02 | -0,02 | -0,02 | -0,02 |
| Announcement Date | 10/03/22 | 05/05/22 | 30/07/22 | 11/11/22 | 10/08/23 | 29/11/23 | 18/04/24 | - | - | - | - |
More events
Past sector events for Addex Therapeutics Ltd
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ADXN Stock
- Calendar Addex Therapeutics Ltd
